Logo

MWG Biotech Seeks to Raise 10M Euros with Convertible Bonds

Nov 19, 2004

NEW YORK, Nov. 19 (GenomeWeb News) - MWG Biotech will issue convertible bonds to raise some €10 million, the Ebersberg, Germany-based company said today.

 

The bonds will pay 6 percent interest per year until Dec. 14, 2007. The bonds are convertible on a 1:1 ratio with MWG Biotech shares.

 

Existing shareholders will be offered the opportunity to purchase one bond for each 3.4 existing shares.

 

The bonds will not be publicly offered and those not underwritten by existing shareholders will be placed with institutional investors, the company said.

Breaking News
The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.